Orr E, Whitney R, Nandeesha N, Kossoff E, Ramachandrannair R
J Child Neurol. 2024; 39(1-2):45-54.
PMID: 38314711
PMC: 11083737.
DOI: 10.1177/08830738241227066.
Martins M, Oliveira A, Martins S, Vieira J, Perdigao P, Fernandes A
Int J Mol Sci. 2023; 24(16).
PMID: 37628781
PMC: 10454663.
DOI: 10.3390/ijms241612603.
Menezes C, Santos D, Nery E, Serpa E, Morais L, Dutra L
Arq Neuropsiquiatr. 2023; 81(4):392-398.
PMID: 36863402
PMC: 10169230.
DOI: 10.1055/s-0042-1758442.
Fang Y, Li D, Wang M, Zhao X, Duan J, Gu Q
Front Neurol. 2022; 13:863826.
PMID: 35685742
PMC: 9171393.
DOI: 10.3389/fneur.2022.863826.
Vanclooster S, Bissell S, Van Eeghen A, Chambers N, Waele L, Byars A
J Neurodev Disord. 2022; 14(1):13.
PMID: 35151277
PMC: 8853020.
DOI: 10.1186/s11689-022-09423-3.
Pharmacotherapy for Seizures in Tuberous Sclerosis Complex.
Nabbout R, Kuchenbuch M, Chiron C, Curatolo P
CNS Drugs. 2021; 35(9):965-983.
PMID: 34417984
DOI: 10.1007/s40263-021-00835-8.
Review of the treatment options for epilepsy in tuberous sclerosis complex: towards precision medicine.
Schubert-Bast S, Strzelczyk A
Ther Adv Neurol Disord. 2021; 14:17562864211031100.
PMID: 34349839
PMC: 8290505.
DOI: 10.1177/17562864211031100.
A Concise Review of Ketogenic Dietary Interventions in the Management of Rare Diseases.
Hettiarachchi D, Lakmal K, Dissanayake V
J Nutr Metab. 2021; 2021:6685581.
PMID: 33628494
PMC: 7899763.
DOI: 10.1155/2021/6685581.
Acute encephalopathy in children with tuberous sclerosis complex.
Numoto S, Kurahashi H, Sato A, Kubota M, Shiihara T, Okanishi T
Orphanet J Rare Dis. 2021; 16(1):5.
PMID: 33407677
PMC: 7789140.
DOI: 10.1186/s13023-020-01646-8.
Inhibition of the mechanistic target of rapamycin induces cell survival via MAPK in tuberous sclerosis complex.
Lu Y, Zhang E, Liu J, Yu J
Orphanet J Rare Dis. 2020; 15(1):209.
PMID: 32807195
PMC: 7433150.
DOI: 10.1186/s13023-020-01490-w.
Ketogenic diets for drug-resistant epilepsy.
Martin-McGill K, Bresnahan R, Levy R, Cooper P
Cochrane Database Syst Rev. 2020; 6:CD001903.
PMID: 32588435
PMC: 7387249.
DOI: 10.1002/14651858.CD001903.pub5.
Safety and Effectiveness of the Prolonged Treatment of Children with a Ketogenic Diet.
Ruiz Herrero J, Canedo Villarroya E, Garcia Penas J, Garcia Alcolea B, Gomez Fernandez B, Puerta Macfarland L
Nutrients. 2020; 12(2).
PMID: 31991539
PMC: 7071522.
DOI: 10.3390/nu12020306.
Effects of antiepileptic drugs in a new TSC/mTOR-dependent epilepsy mouse model.
Koene L, van Grondelle S, Proietti Onori M, Wallaard I, Kooijman N, van Oort A
Ann Clin Transl Neurol. 2019; 6(7):1273-1291.
PMID: 31353861
PMC: 6649373.
DOI: 10.1002/acn3.50829.
Ketogenic diets for drug-resistant epilepsy.
Martin-McGill K, Jackson C, Bresnahan R, Levy R, Cooper P
Cochrane Database Syst Rev. 2018; 11:CD001903.
PMID: 30403286
PMC: 6517043.
DOI: 10.1002/14651858.CD001903.pub4.
Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group.
Kossoff E, Zupec-Kania B, Auvin S, Ballaban-Gil K, Bergqvist A, Blackford R
Epilepsia Open. 2018; 3(2):175-192.
PMID: 29881797
PMC: 5983110.
DOI: 10.1002/epi4.12225.
Ketogenic diet in endocrine disorders: Current perspectives.
Gupta L, Khandelwal D, Kalra S, Gupta P, Dutta D, Aggarwal S
J Postgrad Med. 2017; 63(4):242-251.
PMID: 29022562
PMC: 5664869.
DOI: 10.4103/jpgm.JPGM_16_17.
Ketogenic Diet for the Management of Epilepsy Associated with Tuberous Sclerosis Complex in Children.
Park S, Lee E, Eom S, Kang H, Lee J, Kim H
J Epilepsy Res. 2017; 7(1):45-49.
PMID: 28775955
PMC: 5540690.
DOI: 10.14581/jer.17008.
Cannabidiol in Patients With Intractable Epilepsy Due to TSC: A Possible Medication But Not a Miracle.
Nickels K
Epilepsy Curr. 2017; 17(2):91-92.
PMID: 28490996
PMC: 5416866.
DOI: 10.5698/1535-7511.17.2.91.
The changing face of dietary therapy for epilepsy.
Pasca L, De Giorgis V, Macasaet J, Trentani C, Tagliabue A, Veggiotti P
Eur J Pediatr. 2016; 175(10):1267-76.
PMID: 27586246
DOI: 10.1007/s00431-016-2765-z.
The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions.
Curatolo P, Bjornvold M, Dill P, Ferreira J, Feucht M, Hertzberg C
Drugs. 2016; 76(5):551-65.
PMID: 26927950
DOI: 10.1007/s40265-016-0552-9.